Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Gresonitamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1-kappa
Fidasimtamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
[V-kappa’-VH-h-CH2-CH3_V-kappa-VH’]2
Lorigerlimab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG4-kappa
Livmoniplimab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1-lambda2-[scFv-heavy-kappa]2
Inezetamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Emirodatamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1-kappa
Fazpilodemab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)
Pacanalotamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
(scFv-heavy-kappa)-(scFv-heavy-lambda)-scFc
Pavurutamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3
Izuralimab